1.Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG: Minireview: Gut microbiota: the neglected endocrine organ. Molecular endocrinology 2014, 28(8):1221–1238.
2.Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59–65.
3.Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D et al: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490(7418):55–60.
4.Wei X, Jiang S, Zhao X, Li H, Lin W, Li B, Lu J, Sun Y, Yuan J: Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients. Frontiers in microbiology 2016, 7:1856.
5.Szabo G: Gut-liver axis in alcoholic liver disease. Gastroenterology 2015, 148(1):30–36.
6.Yamashiro Y: Gut Microbiota in Health and Disease. Annals of nutrition & metabolism 2017, 71(3–4):242–246.
7.Bajaj JS: Review article: the modern management of hepatic encephalopathy. Alimentary pharmacology & therapeutics 2010, 31(5):537–547.
8.Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, Olmo JA, Ortega J, Martinez-Valls J, Serra MA et al: Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metabolic brain disease 2012, 27(1):51–58.
9.Ahluwalia V, Betrapally NS, Hylemon PB, White MB, Gillevet PM, Unser AB, Fagan A, Daita K, Heuman DM, Zhou H et al: Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis. Scientific reports 2016, 6:26800.
10.Bajaj JS, Ridlon JM, Hylemon PB, Thacker LR, Heuman DM, Smith S, Sikaroodi M, Gillevet PM: Linkage of gut microbiome with cognition in hepatic encephalopathy. American journal of physiology Gastrointestinal and liver physiology 2012, 302(1):G168–175.
11.Tranah TH, Vijay GK, Ryan JM, Shawcross DL: Systemic inflammation and ammonia in hepatic encephalopathy. Metabolic brain disease 2013, 28(1):1–5.
12.Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Monteith P, Noble NA, Sikaroodi M, Gillevet PM: Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. American journal of physiology Gastrointestinal and liver physiology 2012, 303(6):G675–685.
13.Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y: Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. Journal of hepatology 2010, 53(5):849–855.
14.Wei X, Yan X, Zou D, Yang Z, Wang X, Liu W, Wang S, Li X, Han J, Huang L et al: Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach. BMC gastroenterology 2013, 13:175.
15.Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD: Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Applied and environmental microbiology 2013, 79(17):5112–5120.
16.Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI et al: QIIME allows analysis of high-throughput community sequencing data. Nature methods 2010, 7(5):335–336.
17.Edgar RC: UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nature methods 2013, 10(10):996–998.
18.McDonald D, Price MN, Goodrich J, Nawrocki EP, DeSantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P: An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. The ISME journal 2012, 6(3):610–618.
19.Vernocchi P, Del Chierico F, Putignani L: Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Frontiers in microbiology 2016, 7:1144.
20.Bermingham EN, Maclean P, Thomas DG, Cave NJ, Young W: Key bacterial families (Clostridiaceae, Erysipelotrichaceae and Bacteroidaceae) are related to the digestion of protein and energy in dogs. PeerJ 2017, 5:e3019.
21.Weissenborn K: Minimal hepatic encephalopathy: a permanent source of discussion. Hepatology 2002, 35(2):494–496.
22.Wei X, Zhao J, Jia X, Zhao X, Li H, Lin W, Feng R, Yuan J: Abnormal Gut Microbiota Metabolism Specific for Liver Cirrhosis. Frontiers in microbiology 2018, 9:3051.
23.Foley P, Kermanshahi pour A, Beach ES, Zimmerman JB: Derivation and synthesis of renewable surfactants. Chemical Society reviews 2012, 41(4):1499–1518.
24.Long SL, Gahan CGM, Joyce SA: Interactions between gut bacteria and bile in health and disease. Molecular aspects of medicine 2017, 56:54–65.